Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jiangsu Olive Sensors High-Tech
300507
5
Jing-Jin Electric Technologies
688280
US Stock MarketDetailed Quotes
MYGN Myriad Genetics
- 4.740
- -2.530-34.80%
Trading May 7 12:05 ET
436.89MMarket Cap-4.23P/E (TTM)
5.820High4.600Low4.59MVolume5.700Open7.270Pre Close22.12MTurnover5.11%Turnover RatioLossP/E (Static)92.17MShares29.30052wk High0.62P/B426.01MFloat Cap4.60052wk Low--Dividend TTM89.87MShs Float69.000Historical High--Div YieldTTM16.78%Amplitude1.438Historical Low4.818Avg Price1Lot Size
About Myriad Genetics Company
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolMYGN
Company NameMyriad Genetics
Listing DateOct 6, 1995
Issue Price18.00
Founded1991
CEOMr. Samraat S. Raha
MarketNASDAQ
Employees2700
Fiscal Year Ends12-31
Address322 North 2200 West
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84116
Phone1-801-584-3600
Websitehttp://www.myriad.com
Company Executives
- Name
- Position
- Salary
- Samraat S. Raha
- President, Chief Executive Officer and Director
- 4.39M
- Mark S. Verratti
- Chief Operating Officer
- 3.71M
- Natalie Munk
- Chief Accounting Officer
- --
- Shereen Solaiman
- Chief People Officer
- --
- Jennifer Fox
- Chief Legal Officer
- --
- Scott J. Leffler
- Chief Financial Officer
- 6.15M
- Kevin Richard Haas
- Chief Technology Officer
- --
- Dale Muzzey
- Chief Scientific Officer
- 3.01M
- Margaret Ancona
- Senior Vice President and Chief of Staff
- --
- S. Louise Phanstiel
- Chairman of the Board
- 563.50K
- Rashmi Kumar
- Independent Director
- 433.50K
- Colleen F. Reitan
- Independent Director
- 443.50K
- Paul M. Bisaro
- Independent Director
- 449.35K
- Mark S. Davis
- Independent Director
- 350.00K
- Dr. Lee N. Newcomer, M.D.
- Independent Director
- 448.00K
- Dr. Heiner Dreismann,PhD
- Independent Director
- 443.50K
- Dr. Daniel M. Skovronsky, M.D.,PhD
- Independent Director
- 433.50K
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
